NCT01990872

Brief Summary

This winter-based placebo-controlled, single-dose vitamin D randomized controlled trial (RCT) aims to examine the impact of various levels of habitual calcium intake on dietary vitamin D requirements in older adults stratified by calcium intake. This will provide new data on the impact of different levels of calcium intake, ranging from low/moderate to high, on winter serum 25(OH)D levels, and their utilization and catabolism in adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2013

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 25, 2013

Completed
Last Updated

November 25, 2013

Status Verified

November 1, 2013

Enrollment Period

1.1 years

First QC Date

November 8, 2013

Last Update Submit

November 21, 2013

Conditions

Keywords

Vitamin D status25-hydroxyvitamin DVitamin D3RCTCalcium intakeDietary requirement

Outcome Measures

Primary Outcomes (1)

  • Response of serum 25(OH)D concentration over winter in subjects stratified by calcium intake

    0, 8, 15 weeks

Secondary Outcomes (6)

  • Serum albumin-adjusted calcium

    0, 8, 15 weeks

  • serum parathyroid hormone

    0, 8, 15 weeks

  • Serum 24,25(OH)2D

    0 and 15 weeks

  • Serum 1,25(OH)2D

    0 and 15 weeks

  • Serum free 25(OH)D

    0 and 15 weeks

  • +1 more secondary outcomes

Study Arms (4)

Placebo in high calcium group

PLACEBO COMPARATOR

Placebo + habitual dietary calcium intake (\>1000 mg/d)

Dietary Supplement: Placebo

Vitamin D3 in low/moderate calcium group

ACTIVE COMPARATOR

Vitamin D3 (20 microgram/day) + habitual calcium intake \<700 mg/d

Dietary Supplement: Vitamin D3 (20 micrograms/day)

Placebo in low/moderate calcium group

PLACEBO COMPARATOR

Placebo + habitual calcium intake \<700 mg/d

Dietary Supplement: Placebo

Vitamin D3 in high calcium group

ACTIVE COMPARATOR

Vitamin D3 (20 microgram/day) + habitual calcium intake (\>1000 mg/d)

Dietary Supplement: Vitamin D3 (20 micrograms/day)

Interventions

Vitamin D3 (20 micrograms/day)

Vitamin D3 in high calcium groupVitamin D3 in low/moderate calcium group
PlaceboDIETARY_SUPPLEMENT

Placebo (0 micrograms vitamin D3/day)

Placebo in high calcium groupPlacebo in low/moderate calcium group

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consenting white men and women aged ≥ 50 y

You may not qualify if:

  • Unwilling to discontinue consumption of vitamin D-containing supplements 4 wks before the initiation of the study and throughout the study.
  • Planning to take a winter vacation (during the course of the 15-wk intervention) to a location at which either the altitude or the latitude was predicted to result in significant cutaneous vitamin D synthesis from solar radiation (e.g., a winter sun coastal resort or a mountain ski resort)
  • Use of tanning facilities of any type.
  • Pregnancy or planning to become pregnant during the study
  • A severe medical illness,
  • hypercalcaemia,
  • Known intestinal malabsorption syndrome,
  • Excessive alcohol use,
  • Taking medications known to interfere with vitamin D metabolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Dietary Studies Facility, School of Food and Nutritional Sciences, University College Cork, Cork, Ireland

Cork, Ireland

Location

Related Publications (2)

  • Cashman KD, Kinsella M, Walton J, Flynn A, Hayes A, Lucey AJ, Seamans KM, Kiely M. The 3 epimer of 25-hydroxycholecalciferol is present in the circulation of the majority of adults in a nationally representative sample and has endogenous origins. J Nutr. 2014 Jul;144(7):1050-7. doi: 10.3945/jn.114.192419. Epub 2014 May 14.

  • Cashman KD, Hayes A, O'Donovan SM, Zhang JY, Kinsella M, Galvin K, Kiely M, Seamans KM. Dietary calcium does not interact with vitamin D(3) in terms of determining the response and catabolism of serum 25-hydroxyvitamin D during winter in older adults. Am J Clin Nutr. 2014 Jun;99(6):1414-23. doi: 10.3945/ajcn.113.080358. Epub 2014 Apr 2.

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Kevin D Cashman, BSc. PhD

    University College Cork

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Food and Health

Study Record Dates

First Submitted

November 8, 2013

First Posted

November 25, 2013

Study Start

October 1, 2012

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 25, 2013

Record last verified: 2013-11

Locations